The Clinical and Economic Impact of Delayed Reperfusion Therapy: Real-World Evidence.

Background: Early reperfusion therapy is acknowledged as the most effective approach for reducing case fatality rates in patients with ST-segment elevation myocardial infarction (STEMI).

Objective: Estimate the clinical and economic consequences of delaying reperfusion in patients with STEMI.

Methods: This retrospective cohort study evaluated mortality rates and the total expenses incurred by delaying reperfusion therapy among 2622 individuals with STEMI.